Artal Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Artal Group’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-500,000	Closed	-$7.02M	–	137
2017 Q3	$6.34M	Sell	500,000 -260,000	-34%	-$3.31M	0.11%	57
2017 Q2	$9.02M	Sell	760,000 -40,000	-5%	-$498K	0.16%	39
2017 Q1	$11.8M	Buy	800,000 +300,000	+60%	+$4.86M	0.26%	35
2016 Q4	$8.09M	Buy	500,000 +150,000	+43%	+$2.72M	0.18%	41
2016 Q3	$6.35M	Hold	350,000	–	–	0.13%	47
2016 Q2	$5.76M	Buy	+350,000	New	+$5.66M	0.12%	39

Other funds holding HZNP

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return